SB2549Enacted

Amends TCA Title 53 and Title 63.

Tennessee SB2549 amends Title 53 and Title 63 of the Tennessee Code Annotated to allow healthcare providers subcontracting with the Department of Correction to prescribe buprenorphine products for the treatment of opioid use disorder, provided that specific criteria are met. This bill primarily affects healthcare providers working within the correctional system and individuals undergoing treatment for opioid use disorder. Key provisions include the stipulation that certain listed criteria must be satisfied for the prescription of buprenorphine to be authorized.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

Tennessee SB2549 amends Title 53 and Title 63 of the Tennessee Code Annotated to allow healthcare providers subcontracting with the Department of Correction to prescribe buprenorphine products for the treatment of opioid use disorder, provided that specific criteria are met. This bill primarily affects healthcare providers working within the correctional system and individuals undergoing treatment for opioid use disorder. Key provisions include the stipulation that certain listed criteria must be satisfied for the prescription of buprenorphine to be authorized.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Reeves, Shane

Details
Session

114th General Assembly

Introduced

February 2, 2026

Last Action

April 13, 2026

Pub. Ch. 677

Subjects
OpioidsCorrection, Dept. of

Want to track this bill? Get instant alerts and AI-powered insights.